Profile data is unavailable for this security.
Mergers & acquisitions
| Acquired company | LH:NYQ since announced | Transaction value |
|---|---|---|
| Parkview Health System Inc-Select Outreach Laboratory Assets | 6.25% | -- |
| BioReference Health LLC-Assets Portfolio | 1.67% | -- |
| CHS/Community Health Systems Inc-Select Assets | 16.29% | 195.00m |
| North Mississippi Health Services-Ambulatory Outreach Laboratory Business | 30.17% | -- |
| BioReference Health LLC-Select Assets | 15.77% | 225.00m |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ensign Group Inc | 5.06bn | 343.97m | 12.40bn | 46.00k | 36.51 | 5.55 | 27.64 | 2.45 | 5.84 | 5.84 | 85.94 | 38.42 | 0.9984 | -- | 8.38 | 109,953.10 | 6.80 | 6.66 | 8.11 | 8.05 | 21.07 | 21.89 | 6.81 | 6.82 | -- | -- | 0.0597 | 5.16 | 18.72 | 16.05 | 15.44 | 15.07 | 20.77 | 4.77 |
| Universal Health Services Inc | 16.99bn | 1.38bn | 14.67bn | 86.00k | 11.16 | 2.05 | 7.33 | 0.8634 | 21.04 | 21.04 | 259.66 | 114.75 | 1.14 | -- | 7.08 | 197,587.30 | 9.43 | 6.68 | 11.52 | 7.94 | -- | -- | 8.24 | 6.62 | 0.9595 | 12.35 | 0.3913 | 5.63 | 10.82 | 6.82 | 59.17 | 7.04 | 7.56 | 5.92 |
| Centene Corp | 194.78bn | -6.68bn | 19.96bn | 61.10k | -- | 1.00 | -- | 0.1025 | -13.63 | -13.62 | 394.60 | 40.57 | 2.45 | -- | 10.30 | 3,187,840.00 | -8.39 | 0.4683 | -15.18 | 0.771 | 7.12 | 10.08 | -3.43 | 0.2365 | -- | -0.4145 | 0.4646 | -- | 19.44 | 11.88 | -302.06 | -- | -2.47 | -- |
| Tenet Healthcare Corp | 21.31bn | 1.41bn | 20.31bn | 74.48k | 14.92 | 4.81 | 6.29 | 0.9531 | 15.49 | 15.49 | 234.60 | 48.02 | 0.7271 | 10.89 | 8.06 | -- | 8.08 | 7.28 | 11.63 | 10.40 | 82.26 | 82.59 | 11.11 | 10.10 | 1.68 | 6.61 | 0.5948 | -- | 3.12 | 3.85 | -56.03 | 28.67 | 13.34 | -- |
| Humana Inc | 129.66bn | 1.19bn | 22.20bn | 65.68k | 18.77 | 1.26 | 10.43 | 0.1712 | 9.81 | 9.81 | 1,074.55 | 146.42 | 2.72 | -- | -- | -- | 2.74 | 4.86 | -- | -- | -- | -- | 1.01 | 2.05 | -- | 4.79 | 0.4109 | 19.21 | 10.11 | 10.94 | -1.57 | -18.81 | -10.75 | 3.02 |
| Quest Diagnostics Inc | 11.04bn | 988.00m | 22.76bn | 57.00k | 23.61 | 3.17 | 14.46 | 2.06 | 8.76 | 8.76 | 97.87 | 65.18 | 0.6816 | 39.03 | 8.14 | 193,596.50 | 6.20 | 8.03 | 7.25 | 9.31 | 33.32 | 34.94 | 9.10 | 11.33 | 0.9609 | 6.53 | 0.4377 | 29.29 | 11.78 | 3.18 | 14.09 | -7.06 | 4.74 | 7.68 |
| Labcorp Holdings Inc | 13.77bn | 855.20m | 23.43bn | 70.00k | 27.75 | 2.70 | 15.26 | 1.70 | 10.18 | 10.18 | 163.87 | 104.78 | 0.7466 | 19.61 | 6.13 | 196,647.10 | 4.64 | 6.16 | 5.56 | 7.33 | 28.45 | 32.18 | 6.22 | 9.17 | 1.35 | 5.51 | 0.3934 | -- | 6.97 | 2.40 | 96.73 | -1.96 | 4.13 | -- |
| Natera Inc | 2.12bn | -309.19m | 28.70bn | 4.42k | -- | 22.65 | -- | 13.56 | -2.28 | -2.28 | 15.69 | 9.10 | 1.24 | 13.57 | 7.14 | 478,452.50 | -18.12 | -30.60 | -23.17 | -38.82 | 63.66 | 51.43 | -14.61 | -40.61 | 3.13 | -- | 0.0603 | -- | 56.75 | 41.20 | 56.20 | -- | 72.97 | -- |
Data as of Feb 13 2026. Currency figures normalised to Labcorp Holdings Inc's reporting currency: US Dollar USD
40.91%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 9.03m | 10.89% |
| Victory Capital Management, Inc. (Investment Management)as of 31 Dec 2025 | 5.36m | 6.46% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 4.43m | 5.34% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 3.83m | 4.62% |
| Allspring Global Investments LLCas of 31 Dec 2025 | 2.15m | 2.59% |
| Geode Capital Management LLCas of 31 Dec 2025 | 2.14m | 2.58% |
| Wellington Management Co. LLPas of 30 Sep 2025 | 1.98m | 2.39% |
| Boston Partners Global Investors, Inc.as of 31 Dec 2025 | 1.91m | 2.31% |
| Select Equity Group LPas of 30 Sep 2025 | 1.84m | 2.22% |
| Diamond Hill Capital Management, Inc.as of 31 Dec 2025 | 1.26m | 1.52% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
